REGIONAL PERSPECTIVES
52 CANCER CONTROL 2021
Yunus Mohammed has worked at various programme
management levels, and is a qualified pharmacist with an
MBA, project management certification and health technology
development experiences. He has experience in development,
strategy, pharmaceutical sector, healthcare sector, health
technology, regulatory, intellectual property, and supply chain
sectors. He continues to consult with the SADC Secretariat,
Commonwealth Secretariat and other global partners, working
regionally and internationally on access to medicines projects, and
health systems strengthening.
Layne Robinson currently serves as the Head of Social Policy
Development at the Commonwealth Secretariat. In this role, Layne
leads the Commonwealth's work on Social Policy with particular
focus on Youth, Education, Health and Sport policies, and provides
technical advice to Commonwealth member states whilst working
in partnership with relevant organisations to improve the lives of
Commonwealth citizens.
1. GLOBOCAN, 2018 http://gco.iarc.fr
2. Lodge M. Cancer in the Commonwealth. Cancer Control 2017. Vol 5;pp 62-65
3. Wild CP, Weiderpass E, Stewart BW, editors (2020). World Cancer Report: Cancer Research
for Cancer Prevention. Lyon, France: International Agency for Research on Cancer. Available from: http://publications.iarc.fr/586.
4. Bray F, Ferlay J, Soerjomataram I, Siegel R.L, Torre L.A, Jemal A, Global Cancer Statistics
2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185
Countries, CA: A Cancer Journal for Clinicians, vol. 68 iss. 6 p. 394-424
5. GLOBOCAN, 2020 http://gco.iarc.fr
6. Dorji T, Nopsopon T, Tamang Tenzin S, Pongpirul K, Human papillomavirus vaccination
uptake in low- and middle-income countries: a meta-analysis, EClinical Medicine, Elsevier,
2021.
7. Brisson M, J Kim J, Canfell K, Impact of HPV vaccination and cervical screening on
cervical cancer elimination: a comparative modelling analysis in 78 low-income and
lower-middle-income countries, Lancet 2020, pp. 575-90
8. Jedy-Agba E, Joko WY, Liu B, et al. Trends in cervical cancer incidence in sub-Saharan
Africa. Br J Cancer, 2020; 123:148-154
9. Simms KT, Steinberg J, Caruana M, et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer
in 181 countries, 2020-99: a modelling study. Lancet Oncol 2019; 20: pp. 394-40.
10. OECD, Addressing Challenges in Access to Oncology Medicines, OECD, 2020
11. World Health Organisation, WHO report on cancer setting priorities, investing wisely
and providing care for all, World Health Organisation, 2020.
12. Ochalek J, Abbas K, Claxton K, Jit M, Lomas J. Assessing the value of human papillomavirus
vaccination in Gavi-eligible low-income and middle-income countries. BMJ Glob
Health 2020; 5.
13. World Health Organisation, Global strategy to accelerate the elimination of cervical
cancer as a public health problem. Geneva: World Health Organisation; 2020.
References